Regenerative
medication deals with the translational analysis in tissue engineering and
biology that involves the method of exchange, tissues or organs to revive,
engineering or create human cells. This field holds the promise of engineering
broken tissues and organs by stimulating the bodys own repair mechanisms to
functionally heal antecedently irreparable tissues or organs.
Regenerative medication conjointly includes the chance of growing tissues and
organs within the laboratory and implanting them once the body cannot heal
itself. If regenerated
organs cells would be derived from the patients own tissue or cells, this
could doubtless solve the matter of the shortage of organs obtainable for
donation, and also the drawback of surgical procedure rejection.
Pharmacovigilance
and Pharmacoepidemiology Journal is to publish high quality research in the
discipline of Pharmacovigilance by providing encouragement for editors,
reviewers, authors, and readers to have an uninterrupted scientific
communication.
